S1 Dataset - by Pamela Bakkabulindi (12914980)

“…At the endline, immunization coverage for the Oral Polio Vaccine third dose; Rotavirus vaccine second dose; Pneumococcal Conjugate Vaccine third dose increased in both the intervention and control health facilities. There was a decrease in coverage for the Measles-Rubella vaccine decreased in the intervention health facilities and a decrease in Bacillus Calmette–Guérin vaccine coverage in the control facilities. …”

Change in SOS values over time after collagenase treatment among young, middle-aged, and old groups. by Katsutoshi Miura (9600433)

Combined EZH2 and HDAC inhibitors kill CRPC cells and trigger regression of CRPCs in vivo. by Amy E. Schade (15368259)

Frequencies of different behaviours (Compartment Changes, Escape Attempts, Stimulus Orientation, Stimulus Approach, Stimulus Contact, Grunting, Barking, Excretion), the minimum dis... by Sara Hintze (3216885)

Fluctuations of the free DNA end of flow-stretched DNA. by Fatema Tuz Zohra (11378812)

Proposed cutoff values for men in a very high risk region. by Gleb E. Svinin (18397739)

Data Sheet 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Data Sheet 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Data Sheet 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.pdf by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Data Sheet 4_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Image 5_Effects of gender affirming hormone therapy with testosterone on renal function of assigned female at birth transgender people: a meta-analysis.tif by Daniele Tienforti (11665717)

<i>C. burnetii</i> utilizes α_Vβ₃ integrin for uptake in a cholesterol-dependent manner. by Stacey D. Gilk (208034)

“…When +cholesterol cells were pre-incubated with vitronectin, the major ligand for a α_Vβ₃ integrin, <i>C. burnetii</i> entry decreased by 66% (p = 0.001) and 71% (p<0.0001) as compared to pre-incubation with fibronectin or BSA, respectively. …”

Artificial data: influence of the nature and amount of inter-subject variability on the mean accuracy (± standard error). by Sylvain Takerkart (5659873)

Changes in the body color of cherry shrimp (<i>N</i>. <i>davidi</i> var. red) across different feed treatment groups (Control, AX100, AX100 + BP, AX200, AX200 + BP) over time. by Wei-Wei Hou (3405947)

Fluid accumulation studies. by Moumita Mondal (632557)

“…For fluid accumulation studies 5 days old infant mice were infected with 100 µl of 1×10⁶ CFU/ml of wild type <i>V. cholerae</i>, Δ<i>chiA2</i> mutant, and the complemented strain. …”

Variation in Hg, Mn and Pb of unwashed hair using LA-ICP-MS from 20 individuals. by Gwendolyn K. David (16814057)

Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?—A retrospective study by Katharina Schütte-Nütgen (3234903)

“…</p><p>Results</p><p>Patient survival was similar in both groups, whereas death-censored and overall graft survival were decreased in AKI kidney recipients. AKI kidney recipients showed higher frequencies of DGF and had a reduced eGFR at 7 days, three months and one and three years after RTx. …”

Analysis of the ¹H-¹⁵N HSQC Spectra of mS100A4 in Complex with EGF. by Ching Chang Cho (3080076)

“…<p>(A) Overlaid ¹H-¹⁵N HSQC spectra of 0.5 mM ¹⁵N-labeled free mS100A4 (red) and mS100A4: EGF, molar ratio = 1:0.3 (green), 1:0.6 (blue), and 1:1 (white), with the intensity drop indicated by green boxes. …”

EZH2 and HDAC inhibitors kill CRPCs by up-regulating the common stress responsive transcription factor, ATF3. by Amy E. Schade (15368259)

Expression levels of myosin heavy chain and AMPK-PGC-1α pathway in the skeletal muscles. by Shinichiro Yamada (3600374)

“…<p>The mRNA expression levels of <i>MYH1</i> (encoding MHC type IIx), <i>MYH2</i> (encoding MHC type IIa), and <i>MYH7</i> (encoding MHC type I) normalized to β2-microglobulin levels in the intercostal muscles of SBMA (<i>n</i> = 5) and ALS (<i>n</i> = 5) subjects (A–C). The expression levels of <i>MYH1</i> (A) and <i>MYH2</i> (B) were significantly decreased in subjects with SBMA compared with subjects with ALS. …”